Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.43 |
| ▸ | WNT3A | P56704 | 3/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17844409 | 1.00 | KMT2A (0.51) | KMT2ATRPV1MEN1MAPTCYP3A4 | |
| SCHEMBL19665178 | 0.86 | MAPT (0.49) | KMT2ATRPV1MEN1MAPTCYP3A4 | |
| SCHEMBL21291797 | 0.81 | TRPV1 (0.45) | KMT2ATRPV1MEN1MAPTCYP3A4 | |
| SCHEMBL16552778 | 0.76 | KMT2A (0.83) | KMT2AMEN1MAPTALDH1A1CTNNB1 | |
| SCHEMBL9270268 | 0.76 | CYP3A4 (0.47) | KMT2ATRPV1MEN1MAPTCYP3A4 | |
| Farnesol SCHEMBL28074103 | 0.75 | MAPT (0.65) | KMT2ATRPV1MEN1MAPTCYP3A4 | |
| SCHEMBL822848 | 0.73 | KMT2A (0.70) | KMT2AMEN1MAPTALDH1A1CTNNB1 | |
| SCHEMBL13830267 | 0.73 | KMT2A (0.65) | KMT2AMEN1MAPTCYP3A4ALOX15 | |
| SCHEMBL28830075 | 0.73 | KMT2A (0.65) | KMT2AMEN1MAPTCYP3A4ALOX15 | |
| Farnesol SCHEMBL27733184 | 0.72 | MAPT (0.56) | KMT2ATRPV1MEN1MAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170349858-A1 | PHOTOLABILE FRAGRANCE PRECURSOR COMPOUND | HENKEL AG & CO. KGAA (DE) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349858-A1 | PHOTOLABILE FRAGRANCE PRECURSOR COMPOUND | TRPA1, CYP1A1, TRPV1 | KMT2A 644/4885TRPV1 3/4885MEN1 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.